NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
IARC Working Group on the Identification of Carcinogenic Hazards to Humans. Gentian Violet, Leucogentian Violet, Malachite Green, Leucomalachite Green, and CI Direct Blue 218. Lyon (FR): International Agency for Research on Cancer; 2022. (IARC Monographs on the Identification of Carcinogenic Hazards to Humans, No. 129.)
Gentian Violet, Leucogentian Violet, Malachite Green, Leucomalachite Green, and CI Direct Blue 218.
Show detailsMembers 1
Wendy C. Andersen
Animal Drugs Research Center
United States Food and Drug Administration
Denver, CO
USA
Guosheng Chen
Human Safety Division
Veterinary Drugs Directorate
Health Canada
Ottawa, ON
Canada
Jia-Long Fang
National Center for Toxicological Research
United States Food and Drug Administration
Jefferson, AR
USA
Julia Gohlke (Subgroup Chair, Cancer in Experimental Animals/Mechanistic Evidence)
Department of Population Health Sciences
Virginia-Maryland College of Veterinary Medicine
Blacksburg, VA
USA
Frank Le Curieux (Meeting Chair)
European Chemicals Agency
Helsinki
Finland
Kamila Mitrowska
Department of Pharmacology and Toxicology
National Veterinary Research Institute
Puławy
Poland
Anjoeka Pronk (Subgroup Chair, Exposure Characterization/Cancer in Humans)
Netherlands Organisation for Applied Scientific Research (TNO)
Department of Risk Assessment for Products in Development
Utrecht
The Netherlands
Pascal Sanders
Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (ANSES)
Maisons-Alfort
France
Meng Sun
California Environmental Protection Agency
Office of Environmental Health Hazard Assessment
Sacramento, CA
USA
Gisela de Aragão Umbuzeiro
Laboratory of Ecotoxicology and Genotoxicity
Faculty of Technology
University of Campinas
Limeira, SP
Brazil
Takashi Umemura
Faculty of Animal Health Technology
Yamazaki University of Animal Health Technology
Tokyo
Japan
Invited specialists
None
Representatives
Rosalie Elespuru
Center for Devices and Radiological Health
United States Food and Drug Administration
Silver Spring, MD
USA
Observers
None
IARC Secretariat
Lamia Benbrahim-Tallaa (Responsible Officer; Rapporteur, Mechanistic Evidence)
Felicia Chung
Fatiha El Ghissassi (Rapporteur, Mechanistic Evidence)
Yann Grosse (Rapporteur, Cancer in Experimental Animals)
Kathryn Guyton (Rapporteur, Mechanistic Evidence)
William Gwinn (Rapporteur, Mechanistic Evidence)
Heidi Mattock (Scientific Editor)
Daniel Middleton (Rapporteur, Exposure Characterization)
Adalberto Miranda Filho (Rapporteur, Cancer in Humans)
Mary Schubauer-Berigan (Programme Head; Rapporteur, Cancer in Humans)
Eero Suonio (Rapporteur, Exposure Characterization)
Administrative Assistance
Marieke Dusenberg
Sandrine Egraz
Michel Javin
Jennifer Nicholson
Production Team
Fiona Gould
Niree Kraushaar
Solène Quennehen
Pre- and Post-Meeting Assistance
Claire Beveridge (Technical Editor)
Karen Müller (Managing Editor)
Footnotes
- 1
Working Group Members and Invited Specialists serve in their individual capacities as scientists and not as representatives of their government or any organization with which they are affiliated. Affiliations are provided for identification purposes only. Invited Specialists do not serve as Meeting Chair or Subgroup Chair, draft text that pertains to the description or interpretation of cancer data or participate in the evaluations. Each participant was asked to declare potentially relevant research, employment, and financial interests that are current or that have occurred during the past 4 years. Minimal interests are not disclosed here, and include stock valued at no more than US$ 1000 overall, grants that provide no more than 5% of the research budget of the expert’s organization and that do not support the expert’s research or position, and consulting or speaking on matters not before a court or government agency that does not exceed 2% of total professional time or compensation. All other non-publicly funded grants that support the expert’s research or position and all consulting or speaking on behalf of an interested party on matters before a court or government agency are disclosed as potentially significant conflicts of interests.
- List of Participants - Gentian Violet, Leucogentian Violet, Malachite Green, Leu...List of Participants - Gentian Violet, Leucogentian Violet, Malachite Green, Leucomalachite Green, and CI Direct Blue 218
- cilia- and flagella-associated protein 206 [Homo sapiens]cilia- and flagella-associated protein 206 [Homo sapiens]gi|72534780|ref|NP_001026913.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...